Leàn Rolfes

556 total citations
23 papers, 386 citations indexed

About

Leàn Rolfes is a scholar working on Toxicology, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Leàn Rolfes has authored 23 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Toxicology, 6 papers in Pharmacology and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Leàn Rolfes's work include Pharmacovigilance and Adverse Drug Reactions (16 papers), Drug-Induced Adverse Reactions (5 papers) and Pharmaceutical Practices and Patient Outcomes (5 papers). Leàn Rolfes is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (16 papers), Drug-Induced Adverse Reactions (5 papers) and Pharmaceutical Practices and Patient Outcomes (5 papers). Leàn Rolfes collaborates with scholars based in Netherlands, United Kingdom and New Zealand. Leàn Rolfes's co-authors include Florence van Hunsel, Eugène van Puijenbroek, Katja Taxis, Kees van Grootheest, Linda Härmark, Tim Schutte, Gurumurthy Parthasarathi, Andries S. Koster, Daisuke Tanaka and Lara Magro and has published in prestigious journals such as SHILAP Revista de lepidopterología, Vaccine and British Journal of Clinical Pharmacology.

In The Last Decade

Leàn Rolfes

23 papers receiving 380 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leàn Rolfes Netherlands 11 270 110 103 85 71 23 386
Tomas Bergvall Sweden 10 236 0.9× 64 0.6× 57 0.6× 68 0.8× 24 0.3× 12 356
Georgy Genov Netherlands 9 199 0.7× 144 1.3× 61 0.6× 59 0.7× 13 0.2× 14 389
Cecilia Biriell Sweden 7 189 0.7× 57 0.5× 87 0.8× 84 1.0× 48 0.7× 10 423
Daniele Sartori Sweden 7 149 0.6× 56 0.5× 57 0.6× 45 0.5× 22 0.3× 16 255
J O Awobusuyi Nigeria 8 165 0.6× 62 0.6× 88 0.9× 28 0.3× 54 0.8× 23 370
Elizabeth Murphy United States 4 195 0.7× 72 0.7× 92 0.9× 48 0.6× 39 0.5× 5 305
P Mishra India 10 155 0.6× 74 0.7× 80 0.8× 46 0.5× 98 1.4× 48 407
J.M. Arnau Spain 10 159 0.6× 49 0.4× 82 0.8× 35 0.4× 67 0.9× 18 329
Ambrose O. Isah Nigeria 11 123 0.5× 85 0.8× 60 0.6× 27 0.3× 82 1.2× 38 322
Phil Tregunno United Kingdom 7 188 0.7× 51 0.5× 61 0.6× 46 0.5× 11 0.2× 13 269

Countries citing papers authored by Leàn Rolfes

Since Specialization
Citations

This map shows the geographic impact of Leàn Rolfes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leàn Rolfes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leàn Rolfes more than expected).

Fields of papers citing papers by Leàn Rolfes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leàn Rolfes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leàn Rolfes. The network helps show where Leàn Rolfes may publish in the future.

Co-authorship network of co-authors of Leàn Rolfes

This figure shows the co-authorship network connecting the top 25 collaborators of Leàn Rolfes. A scholar is included among the top collaborators of Leàn Rolfes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leàn Rolfes. Leàn Rolfes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ekhart, Corine, et al.. (2023). Patient Experiences with the Use of Medicinal Cannabis in the Netherlands: A Cohort-Event Monitoring Study. SHILAP Revista de lepidopterología. 2(1). 138–146. 1 indexed citations
2.
Rolfes, Leàn, et al.. (2023). Spontaneously reported adverse events following COVID-19 basic and booster immunizations in the Netherlands. Vaccine. 41(29). 4319–4326. 5 indexed citations
3.
Härmark, Linda, et al.. (2022). An evaluation of postmarketing reports of hyperglycaemia associated with dolutegravir for treatment of HIV in Eswatini. AIDS Research and Therapy. 19(1). 54–54. 6 indexed citations
4.
Rolfes, Leàn, et al.. (2022). COVID-19 vaccine reactogenicity – A cohort event monitoring study in the Netherlands using patient reported outcomes. Vaccine. 40(7). 970–976. 20 indexed citations
5.
6.
Hunsel, Florence van, Linda Härmark, & Leàn Rolfes. (2019). Fifteen years of patient reporting –what have we learned and where are we heading to?. Expert Opinion on Drug Safety. 18(6). 477–484. 17 indexed citations
7.
Rolfes, Leàn, et al.. (2019). Interaction of OTC drug noscapine and acenocoumarol and phenprocoumon. British Journal of Clinical Pharmacology. 85(5). 1041–1043. 4 indexed citations
8.
9.
Rolfes, Leàn, Andries S. Koster, Lara Magro, et al.. (2018). What Future Healthcare Professionals Need to Know About Pharmacovigilance: Introduction of the WHO PV Core Curriculum for University Teaching with Focus on Clinical Aspects. Drug Safety. 41(11). 1003–1011. 50 indexed citations
10.
Rolfes, Leàn, Florence van Hunsel, Ola Caster, et al.. (2018). Does patient reporting lead to earlier detection of drug safety signals? A retrospective comparison of time to reporting between patients and healthcare professionals in a global database. British Journal of Clinical Pharmacology. 84(7). 1514–1524. 13 indexed citations
11.
Schutte, Tim, Jelle Tichelaar, Leàn Rolfes, et al.. (2017). Feasibility and Educational Value of a Student-Run Pharmacovigilance Programme: A Prospective Cohort Study. Drug Safety. 40(5). 409–418. 25 indexed citations
12.
Rolfes, Leàn, et al.. (2017). First experiences with a tool to measure the level of clinical information present in adverse drug reaction reports. Expert Opinion on Drug Safety. 17(2). 111–115. 13 indexed citations
13.
14.
Rolfes, Leàn, et al.. (2017). How do Adverse Drug Reactions Influence the Patient's Daily Life? Qualitative Analysis on Spontaneous Reports by Patients. Data Archiving and Networked Services (DANS). 40(10). 964–964. 1 indexed citations
15.
Rolfes, Leàn, Florence van Hunsel, Katja Taxis, & Eugène van Puijenbroek. (2016). The Impact of Experiencing Adverse Drug Reactions on the Patient’s Quality of Life: A Retrospective Cross-Sectional Study in the Netherlands. Drug Safety. 39(8). 769–776. 48 indexed citations
16.
Rolfes, Leàn, et al.. (2016). The validity and reliability of a signal impact assessment tool. Pharmacoepidemiology and Drug Safety. 25(7). 815–819. 11 indexed citations
17.
Rolfes, Leàn, et al.. (2016). Actions in response to drug safety signals arising from a spontaneous reporting system: Retrospective study in The Netherlands. International Journal of Risk & Safety in Medicine. 28(2). 115–123. 3 indexed citations
18.
Rolfes, Leàn, Florence van Hunsel, Kees van Grootheest, & Eugène van Puijenbroek. (2015). Feedback for patients reporting adverse drug reactions; satisfaction and expectations. Expert Opinion on Drug Safety. 14(5). 625–632. 9 indexed citations
19.
Rolfes, Leàn, et al.. (2014). Adverse drug reaction reports of patients and healthcare professionals—differences in reported information. Pharmacoepidemiology and Drug Safety. 24(2). 152–158. 58 indexed citations
20.
Rolfes, Leàn, et al.. (2013). Important information regarding reporting of adverse drug reactions: a qualitative study. International Journal of Pharmacy Practice. 22(3). 231–233. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tomas Bergvall Breakdown of academic impact, for papers by Georgy Genov Breakdown of academic impact, for papers by Cecilia Biriell Breakdown of academic impact, for papers by Daniele Sartori Breakdown of academic impact, for papers by J O Awobusuyi Breakdown of academic impact, for papers by Elizabeth Murphy Breakdown of academic impact, for papers by P Mishra Breakdown of academic impact, for papers by J.M. Arnau Breakdown of academic impact, for papers by Ambrose O. Isah Breakdown of academic impact, for papers by Phil Tregunno
Rankless by CCL
2026